Policy digest

Approval of anticancer drugs to be accelerated

China will speed up the registration and approval of anticancer drugs produced by both domestic and foreign pharmaceutical companies, according to a notice released by the General Office of the State Council on June 4.

The notice on the key tasks for deepening reform of the pharmaceutical and medical system also called for heightened efforts in cancer prevention and screening and the enabling of early diagnosis and treatment.